United States · 
What does Vivo Capital invest in?
Vivo Capital invests most often at Series A and Series B (52% of the rounds on record), in sectors such as Longevity, Wellbeing and Health.
Vivo Capital highlights
- 01
37 cheques in the last 12 months
- 02
Mostly Series A and Series B: 52% of its rounds
- 03
Sole investor in 8 rounds, median $4.9M
- 04
1 exits from the portfolio
What they do
Filed 2 private fund offerings with the SEC, the most recent in 2026-08From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- $10M – $50M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- LongevityWellbeingHealth
- Based in
- Palo Alto, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first140 appearances
- 2026
31 rounds
- Sept
- Sept
- Sept
- Aug
- Jul
- Jul
- Jun
- Jun
- Jun
- Jun
- May
- May
- May
- Apr
- Apr
- Apr
- Apr
- Apr
- Mar
- Mar
- Mar
- Mar
- Mar
- Mar
- Feb
- Feb
- Feb
- Jan
- Jan
- Jan
- Jan
- 2025
23 rounds
- Dec
- Dec
- Dec
- Dec
- Nov
- Nov
- Oct
- Oct
- Sept
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration16 named
ACAlbert ChaA Managing Member of the General PartneriFiling they signed
CYChen YuManaging Member of the General PartneriFiling they signed
CHCinthia Hui-Hsin SheuPartner / Chief Operating OfficeriForm ADV
DDDanDan DongManaging Member of the General PartneriFiling they signed
DLDavid LiuManaging Member of the General PartneriFiling they signed
EGEdgar George EnglemanA Managing Member of the General PartneriFiling they signed
FFFrank Fang-Chien KungA Managing Member of the General PartneriFiling they signed
GAGaurav AggarwalManaging Members of the General PartneriFiling they signed
HLHongbo LuManaging Member of the General PartneriFiling they signed
JBJack Bech NielsenManaging Member of the General PartneriFiling they signed
KDKevin DaiManaging Member of the General PartneriFiling they signed
LHLu HongboManaging Member of the General PartneriFiling they signed
MSMahendra ShahManaging Members of the General PartneriFiling they signed
MJMichael J. ChangManaging Member of the General PartneriFiling they signed
S(Shan (nmn) FuManaging Member of the General PartneriFiling they signed
Z(Zhanping (nmn) WuPartner / General Counsel / Chief Compliance OfficeriForm ADV
We also hold 44 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$6.1Bassets it managesOct 2026
10+funds on filenumbered funds in its name
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- VIVO Capital LLC
- SEC number
- CRD 159868
Funds on its Form ADV
15 private funds, $6.0B in gross assets · filed Sept 2024
Venture 7Private equity 5Closed-end private fund that 3
- Vivo Capital Fund IX, L.P.Private equity46 investors$2.6B
- Vivo Opportunity Fund Holdings, L.P.Closed-end private fund that65 investors$1.0B
- Vivo Capital Fund VIII, L.P.Private equity59 investors$609M
- Vivo Capital Fund X, L.P.Private equity16 investors$548M
- Vivo Innovation Fund II Holdings, L.P.Venture35 investors$340M
- Vivo Super VIII LimitedVenture6 investors$225M
- Vivo Co-Invest (C), L.P.Private equity2 investors$150M
- Vivo ASIA Opportunity Fund Holdings, L.P.Closed-end private fund that21 investors$118M
- Vivo Capital Surplus Fund VIII, L.P.Private equity9 investors$84M
- Vivo Opportunity Co-Invest, L.P.Closed-end private fund that2 investors$81M
And 5 more on the filing.
Who backs their funds
1 LP on record in Vivo Capital's funds
- Committed
- $146M
- Funds
- 3
- Vintages
- 2015 to 2018
The institutions that put money into its funds, which the firm then invests in companies.Source: the pension's own report, latest Jun 2025.
- California State Teachers Retirement System3 funds$146M
Fund Vintage Committed Vivo Capital Fund IX 2018 $100M Vivo Capital Fund VIII 2015 $40M Vivo Capital Surplus Fund VIII 2015 $6.0M
What they claim to have backed
From their own portfolio page (on their website)
38 of 60 we have independently watched raise
Aadi BioscienceAjaxtherapeuticsAlto NeuroscienceAscendis PharmaBolt BiotherapeuticsCaidyaCidara TherapeuticsCompass PathwaysCompass TherapeuticsEpibiologicsIO BiotechImmune-Onc TherapeuticsInspirnaKinaset TherapeuticsKira PharmaceuticalsMagnolia Medical TechnologiesMetacrineNeocisOricell TherapeuticsOssium HealthPasithea TherapeuticsPrecision BioSciencesProviviPulmocideRayzebioSanegene BioSera PrognosticsSilence TherapeuticsSinovac BiotechSonoTheraTebra TechnologiesTerns PharmaceuticalsTourmaline BioTranquis TherapeuticsVerona PharmaVisirna TherapeuticsZai LabZenas BiopharmaAchieve Life SciencesAgno PharmaAkiraBioAvadel PharmaceuticalsAvistone PharmaceuticalsBioDlinkBlossomHill TherapeuticsBonraybioCreaterna Science and TechnologyDominique DutscherEsco AsterEsco Lifesciences GroupEvaheart Medical DeviceGenetronHCMed InnovationsHanchorBioHistowizIVERIC BioInstil BioLepu BiopharmLepu Scientech Medical TechnologyMereo BioPharma Groupand 15 more
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Aspreva Pharmaceuticals CorpBought by Galenica Ltd.UndisclosedOct 2007
An exit counts when it came after the firm's first round in the company. From historical deal records.